Literature DB >> 15197016

Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans.

Tomoshige Hayashi1, Edward J Boyko, Donna L Leonetti, Marguerite J McNeely, Laura Newell-Morris, Steven E Kahn, Wilfred Y Fujimoto.   

Abstract

BACKGROUND: Visceral adiposity is generally considered to play a key role in the metabolic syndrome.
OBJECTIVE: To examine the relationship between directly measured visceral adiposity and the risk for incident hypertension, independent of other adipose depots and fasting plasma insulin levels.
DESIGN: Community-based prospective cohort study with 10- to 11-year follow-up.
SETTING: King County, Washington. PARTICIPANTS: 300 Japanese Americans with a systolic blood pressure less than 140 mm Hg and a diastolic blood pressure less than 90 mm Hg who were not taking antihypertensive medications, oral hypoglycemic medications, or insulin at study entry. MEASUREMENTS: Abdominal, thoracic, and thigh fat areas were measured by using computed tomography. Total subcutaneous fat area was calculated as the sum of these fat areas excluding the intra-abdominal fat area. Hypertension during follow-up was defined as having a systolic blood pressure of 140 mm Hg or greater, having a diastolic blood pressure of 90 mm Hg or greater, or taking antihypertensive medications.
RESULTS: There were 92 incident cases of hypertension during the follow-up period. The intra-abdominal fat area was associated with an increased risk for hypertension. Multiple-adjusted odds ratios of hypertension for quartiles of intra-abdominal fat area (1 = lowest; 4 = highest) were 5.07 (95% CI, 1.75 to 14.73) for quartile 3 and 3.48 (CI, 1.01 to 11.99) for quartile 4 compared with quartile 1 after adjustment for age, sex, fasting plasma insulin level, 2-hour plasma glucose level, body mass index, systolic blood pressure, alcohol consumption, smoking status, and energy expenditure through exercise (P = 0.003 for quadratic trend). The intra-abdominal fat area remained a significant risk factor for hypertension, even after adjustment for total subcutaneous fat area, abdominal subcutaneous fat area, or waist circumference; however, no measure of these fat areas was associated with risk for hypertension in models that contained the intra-abdominal fat area. LIMITATIONS: It is not known whether these results pertain to other ethnic groups.
CONCLUSIONS: Greater visceral adiposity increases the risk for hypertension in Japanese Americans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197016     DOI: 10.7326/0003-4819-140-12-200406150-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  91 in total

1.  Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study.

Authors:  Yuichiro Yano; Wanpen Vongpatanasin; Colby Ayers; Aslan Turer; Alvin Chandra; Mercedes R Carnethon; Philip Greenland; James A de Lemos; Ian J Neeland
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

2.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

3.  Favorable effects of non-instrumental resistance training on fat distribution and metabolic profiles in healthy elderly people.

Authors:  Shigeki Tsuzuku; Taeko Kajioka; Hidetoshi Endo; Robert D Abbott; J David Curb; Katsuhiko Yano
Journal:  Eur J Appl Physiol       Date:  2007-01-12       Impact factor: 3.078

4.  Sagittal abdominal diameter is a better predictor than body mass index for duration of laparoscopic left colectomy.

Authors:  Daniel Clerc; Benjamin Blaser; Nicolas Demartines; Dimitrios Christoforidis
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

5.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

6.  Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.

Authors:  Ellen W Demerath; Derek Reed; Nikki Rogers; Shumei S Sun; Miryoung Lee; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

7.  Reduction in visceral adiposity is highly related to improvement in vascular endothelial dysfunction among obese women: an assessment of endothelial function by radial artery pulse wave analysis.

Authors:  Si-Hoon Park; Kyung-Won Shim
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

Review 8.  Is adiposopathy (sick fat) an endocrine disease?

Authors:  H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard
Journal:  Int J Clin Pract       Date:  2008-08-04       Impact factor: 2.503

9.  Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study.

Authors:  Shilpa H Jain; Joseph M Massaro; Udo Hoffmann; Guido A Rosito; Ramachandran S Vasan; Annaswamy Raji; Christopher J O'Donnell; James B Meigs; Caroline S Fox
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 19.112

10.  Blood pressure control and components of the metabolic syndrome: the GOOD survey.

Authors:  Walter Zidek; Lisa Naditch-Brûlé; Stefano Perlini; Csaba Farsang; Sverre E Kjeldsen
Journal:  Cardiovasc Diabetol       Date:  2009-09-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.